Kruskal-Walis test revealed significant RUNX3 protein level associations with astrocytoma pathological grade (p=0.007), patient 2-year survival after tumour resection (≤24 and >24 months, p=0.001), and patient disease appearance age (≤50 and >50 years; p=0.037), but not gender (p=0.707), Table 1. The gene discussed is RUNX3; the disease is astrocytoma (excluding glioblastoma).